

For Subcutaneous Injection
Composition: LL-37 (CAP-18) (Cathelicidin)
Dosage: 5 mg/vial
Unit: 2 mL Multidose Vial
Form: Lyophilized Powder
Manufactured by Peptide Hubs
Peptide Hubs LL-37 5 mg (the active human cathelicidin fragment derived from CAP-18) is a lyophilized, research-grade peptide supplied in a sterile 2 mL vial for qualified laboratory use. LL-37 is widely discussed in the context of innate immunity and cell-surface interface biology in experimental models, where it is examined for roles in barrier environments and immune signaling. This 5 mg presentation is designed for pilot studies, method development, and short-horizon protocols that value precise reconstitution and minimal waste.
Important: The information below is provided for educational discussion within a lawful research context. This product is not a drug, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease. Purchase and use assume qualified individuals or laboratories operating under applicable regulations and SOPs.
LL-37 is the only human cathelicidin peptide identified to date, generated by proteolytic processing of the CAP-18 precursor. In test systems, LL-37 is explored for its membrane-interaction behavior and its participation in innate immune signaling pathways under controlled conditions. For a concise primer on innate immunity that helps frame sampling windows, endpoints, and study design, see the NCBI/Bookshelf overview on the innate immune system here.
The 5 mg vial is ideal for labs building SOPs and dialing in timing, solvent volume, storage routines, and handling consistency. Smaller fills allow you to:
Once your timing, storage, and record-keeping are validated, your team can scale to larger fills for extended timelines.
LL-37 is frequently studied where barrier environments and innate pathways are of interest. To generate interpretable data, anchor your protocol in consistency:
Because LL-37 is often discussed for multi-pathway effects in in vitro and ex vivo contexts, many teams prefer separate protocol arms rather than stacking mechanisms in a single arm. This preserves interpretability when you compare across dermal, tissue-recovery, metabolic, or performance-adjacent hypotheses.
Timing: Lock the administration-to-meal interval and administration-to-training interval so you can attribute differences to the protocol rather than lifestyle drift.
Confounders: Stabilize sleep duration/quality, hydration, caffeine/stimulants, and training volume/density. If your audience includes bodybuilders or fitness enthusiasts who vary protocols frequently, consider a "no changes" rule during the study window.
Integrity: Use checklists. Verify labels, concentration math, and timestamps. Keep chain-of-custody notes if multiple operators are involved. These details are crucial when you rerun a pilot or interpret outliers.
Peptide Hubs emphasizes batch uniformity, clear labeling, and protective packaging for reliable USA transit. Our catalog structure helps teams design separate, mechanism-specific programs instead of stacking endpoints into a single arm—an approach that keeps data cleaner and more publication-ready. For buyers searching "Buy LL-37 USA" and "Peptide Hubs LL-37," this 5 mg vial offers a practical balance between precision and flexibility.
If your lab values SOP-driven consistency, pilot-friendly fill sizes, and clean comparisons across mechanisms, LL-37 5 mg fits neatly into a rigorous workflow. The smaller fill simplifies reconstitution math, reduces waste, and lets you run multi-window pilots without tying up inventory—all with discreet, fast USA shipping and straightforward product presentation for smooth auditing.
Regulatory Notice: Not intended for human consumption. For lawful laboratory research by qualified individuals only.
LL-37 is the human cathelicidin peptide examined in experimental models of innate immunity and barrier biology, with protocols emphasizing strict timing and handling control.
5 mg is pilot-friendly, reduces waste, and supports precise reconstitution for micro-measurement—ideal for method development before scaling to larger fills or longer timelines.
Keep lyophilized vials cool, dry, and protected from light. Reconstitute with bacteriostatic water using sterile technique, refrigerate after reconstitution, and avoid freeze–thaw cycling per SOP.
For clean data, evaluate different mechanisms in separate arms. For contrasts, see GHK-CU 10 mg (dermal) or BPC-157 (tissue-recovery) in parallel programs.
No. It is a research-grade peptide not intended to diagnose, treat, cure, or prevent any disease. Use is limited to lawful laboratory research by qualified individuals.
Please log in to write LL-37 5 mg review.
For Intramuscular Injection
Composition:
- Testosterone Propionate 42 mg
- Testosterone Phenylropionate 84 mg
- Testosterone Isocaproate 84 mg
- Testosterone Decanoate 140 mg
Mixed Dosage: 350 mg/1 mL
Unit: 10 mL Multidose Vial
Manufactured by Kalpa Pharmaceuticals
For Oral Administration
Composition: Clenbuterol Hydrochloride
Dosage: 40 mcg/tablet
Unit: 100 Tablets
Manufactured by Axiolabs
Laboratory Test: View Lab Report